Edition:
United Kingdom

Sienna Biopharmaceuticals Inc (SNNA.OQ)

SNNA.OQ on NASDAQ Stock Exchange Global Select Market

21.87USD
7:41pm GMT
Change (% chg)

$1.82 (+9.08%)
Prev Close
$20.05
Open
$20.06
Day's High
$22.08
Day's Low
$20.02
Volume
20,848
Avg. Vol
20,179
52-wk High
$28.95
52-wk Low
$17.42

Select another date:

Thu, Nov 9 2017

BRIEF-Sienna Biopharmaceuticals posts qtrly loss per share $1.12‍​

* Sienna Biopharmaceuticals reports third quarter 2017 financial results

BRIEF-Sienna Biopharmaceuticals announces first patient dosed in phase 2B trial of topical SNA-120

* Sienna Biopharmaceuticals announces first patient dosed in phase 2B trial of topical SNA-120

BRIEF-Sienna Biopharmaceuticals reports Q2 loss of $6.50/shr

* Sienna Biopharmaceuticals reports second quarter 2017 financial results

BRIEF-Partner Fund reports 7.7 pct passive stake in Sienna Biopharmaceuticals‍​

* Partner Fund Management LP reports 7.7 percent passive stake in Sienna Biopharmaceuticals Inc as of July 27, 2017 - SEC filing‍​ Source text: (http://bit.ly/2vfsuuL) Further company coverage:

BRIEF-Sienna Biopharmaceuticals shares open 27 pct above IPO price in debut

* Sienna Biopharmaceuticals Inc shares open at $19.05 in debut on the NASDAQ versus IPO price of $15.00

Select another date: